Capital increase

New fully paid-up share capital: CHF 210,200, divided into 117,597 registered shares of CHF 1 and 92,603 registered shares of CHF 1 type A, preferential with respect to liquidation proceeds, all with …

Capital increase

New fully paid-up share capital: CHF 196,421, divided into 117,597 registered shares of CHF 1 and 78,824 registered shares of CHF 1 type A, preferential with respect to liquidation proceeds, all with …

Capital increase

New fully paid-up share capital: CHF 145,960, divided into 117,597 registered shares of CHF 1 and 28,363 registered shares of CHF 1 type A, preferential with respect to liquidation proceeds, all with …

Capital increase

New fully paid-up share capital: CHF 145,360, divided into 116,997 registered shares of CHF 1 and 28,363 registered shares of CHF 1 type A, preferential with respect to liquidation proceeds, all with …

Capital increase

New fully paid-up share capital: CHF 134,015, divided into 116’997 registered shares of CHF 1 and 17,018 registered shares of CHF 1 type A, preferential with respect to liquidation proceeds, all…

Capital increase

New share capital: CHF 113,451, paid up to CHF 63,451, divided into 100,000 registered shares of CHF 1 and 13,451 registered shares of CHF 1, all with transfer restrictions as per the Articles of Asso…

New person

Mr. David Bonzon is appointed as a new member of the board of directors.

New person

Mr. Georges Muller is appointed as a new member of the board of directors.

Initial Capital

New capital: CHF 100,000, paid up to CHF 50,000, divided into 100,000 registered shares of CHF 1, with transfer restrictions as per the Articles of Association.

Incorporation

The limited company SEED Biosciences SA is registered in the commercial register of the Canton of Vaud.

1